The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase
Open accessAbstract
We have investigated whether (i) endotoxaemia caused by E. coli lipopolysaccharide in the anaesthetized rat causes a multiple organ dysfunction syndrome (MODS; e.g. circulatory failure, renal failure, liver failure), and (ii) an enhanced formation of nitric oxide (NO) due to induction of inducible NO synthase (iNOS) contributes to the MODS. In addition, this study elucidates the beneficial and adverse effects of aminoethyl‐isothiourea (AE‐ITU), a relatively selective inhibitor of iNOS activity, and N G‐methyl‐l‐arginine (l‐NMMA), a non‐selective inhibitor of NOS activity on the MODS caused by endotoxaemia. In the anaesthetized rat, LPS caused a fall in mean arterial blood pressure (MAP) from 117±3mmHg (time 0) to 97±4mmHg at 2 h (P<0.05, n=15) and 84±4mmHg at 6 h (P < 0.05, n= 15). The pressor effect of noradrenaline (NA, 1 μg kg−1, i.v.) was also significantly reduced at 1 to 6 h after LPS (vascular hyporeactivity). Treatment of LPS‐rats with AE‐ITU (1 mg kg−1, i.v. plus 1 mg kg−1 h−1 starting at 2 h after LPS) caused only a transient rise in MAP, but significantly attenuated the delayed vascular hyporeactivity seen in LPS‐rats. Infusion of l‐NMMA (3 mg kg−1, i.v. plus 3 mg kg−1 h−1) caused a rapid and sustained rise in MAP and attenuated the delayed vascular hyporeactivity to NA. Neither AE‐ITU nor l‐NMMA had any effect on either MAP or the pressor effect elicited by NA in rats infused with saline rather than LPS. Endotoxaemia for 6 h was associated with a significant rise in the serum levels of aspartate or alanine aminotransferase (i.e. GOT or GPT), γ‐glutamyl‐transferase (γGT), and bilirubin, and hence, fiver dysfunction. Treatment of LPS‐rats with AE‐ITU significantly attenuated this liver dysfunction (rise in GOT, GPT, yGT and bilirubin) (P <0.05, n=10). In contrast, l‐NMMA reduced the increase in the serum levels of γGT and bilirubin, but not in GOT and GPT (n = 5). Injection of LPS also caused a time‐dependent, but rapid (almost maximal at 2 h), increase in the serum levels of urea and creatinine, and hence, renal dysfunction. This renal dysfunction was not affected by either AE‐ITU (n= 10) or l‐NMMA (n= 5). In rats infused with saline rather than LPS, neither AE‐ITU (n = 4) nor l‐NMMA (n = 4) had any significant effect on the serum levels of GOT* GPT, yGT, bilirubin, creatinine or urea. Endotoxaemia for 6 h resulted in a 4.5 fold rise in the serum levels of nitrite (9.13 ±0.77 μ m, P < 0.01, n= 15), which was significantly reduced by treatment with AE‐ITU (6.32±0.48 μm, P <0.05, n=10) or l‐NMMA (5.10±0.40 μ m, P < 0.05, n = 5). In addition, endotoxaemia for 6 h was also associated with a significant increase in iNOS activity in lung and liver homogenates, which was significantly reduced in lung or liver homogenates obtained from LPS‐rats treated with either AE‐ITU or l‐NMMA. Thus, AE‐ITU or l‐NMMA (i) inhibits iNOS activity in LPS‐rats without causing a significant increase in MAP in rats infused with saline and, hence inhibition of endothelial NOS activity, and (ii) attenuates the delayed circulatory failure as well as the liver dysfunction caused by endotoxaemia in the rat. Thus, an enhanced formation of NO may contribute to the development of fiver failure in endotoxic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite
Hibbs, J. B., Taintor, R. R., & Vavrin, Z. (1987) · Science · doi:10.1126/science.2432665 · Cited by 1,527
Cited by
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
Jaeschke, H. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00342.2002 · Cited by 852
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
Wiest, R., & Groszmann, R. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31432 · Cited by 471
Intensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Nitric oxide and intestinal inflammation
Kubes, P., & McCafferty, D.-M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00480-0 · Cited by 347
Thiemermann, C. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00410-7 · Cited by 303
Self-citation
Metadata
- Authors
- Thiemermann, C., Ruetten, H., Wu, C., & Vane, J. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1995-12
- Volume
- 116
- Issue
- 7
- Pages
- 2845-2851
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2081237387
- Cited by
- 211
- References
- 3
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb15935.x
- The paper
- Thiemermann, C., Ruetten, H., Wu, C., & Vane, J. R. (1995). The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb15935.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.